This inventor holds 2 USPTO granted patents. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Nobuyoshi Shimizu: Innovator in Immunosuppressive Compositions
Introduction
Nobuyoshi Shimizu is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Shimizu's work focuses on enhancing immunosuppressive therapies, particularly in the context of organ transplantation.
Latest Patents
Shimizu's latest patents include compositions that potentiate immunosuppressive activity. These compositions comprise a phosphoric acid diester compound, which can effectively suppress acute rejection after transplantation. His second patent details a method for the viable preservation of lung grafts, utilizing a similar phosphoric acid diester compound. This invention aims to improve the preservation of lung grafts, ensuring better outcomes for transplant patients.
Career Highlights
Nobuyoshi Shimizu is currently associated with Senju Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for immunosuppressive therapies.
Collaborations
Shimizu has collaborated with notable colleagues, including Motoi Aoe and Ken-ichi Yoshida, contributing to the advancement of their shared research goals.
Conclusion
Nobuyoshi Shimizu's contributions to immunology through his patents reflect his dedication to improving transplant outcomes. His innovative approaches continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile